VEGFA and hepatocellular carcinoma: Due to the ineffectiveness of chemotherapy, most of the current approved systemic treatments for HCC are tyrosine kinase inhibitors (TKI), vascular endothelial growth factor (VEGF) inhibitors, and immunotherapy agents [5].